Eukaryotic production of RBD is, however, mandatory for vaccination success, since only antibodies directed against folded RBD are able to block interaction of the viral S-protein and the cellular receptor ACE-2 and are therefore highly relevant to protect against infection with SARS-CoV-2 [52,53]. The gene discussed is ACE2; the disease is infection.